Montreal, Canada – November 23, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that some of its management team members will be participating in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1 and 2, 2020.
Conference: Piper Sandler Virtual Healthcare Conference Pre-recorded fireside chat link: https://pipersandler.zoom.us/rec/play/DzM2ijjKkXgWuhzWySeHQJNIC4BQ6Ogr5J0niJyS3ssfq5mHVItC87xcOsLrajOpcg40gTuwOGssIeyW.e9WptH4CKoRvgK5k
Montreal, Canada – November 16, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today highlighted new data on the mechanism of effect of tesamorelin presented in an oral presentation given today by Lindsay T. Fourman, M.D., of the Metabolism Unit, Department of …Lire la suite
Conference: Credit Suisse Virtual Healthcare Conference Date and Time: Tuesday, November 10, 2020 at 8:45 a.m. ET Webcast Link: https://kvgo.com/credit-suisse/theratech-november-2020
Montreal, Canada – November 6, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that an oral presentation including data on the mechanism of effect of tesamorelin in nonalcoholic fatty liver disease (NAFLD) will be given by Lindsay T Fourman, MD, …Lire la suite
Montreal, Canada – November 3, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Jovan Antunovic, Senior Vice President and Chief Commercial Officer, is leaving the Company to assume a new position. His resignation will be effective November 13, 2020. …Lire la suite
Conference: B. Riley Securities Liver Disease Therapeutics Day 2020 Date and Time: Thursday, October 29, 2020 at 12:10 pm ET Webcast Link: https://www.webcaster4.com/Webcast/Page/2433/38305 B. Riley Representative: Mayank Mamtani
Montreal, Canada – October 22, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences. Riley Securities Liver Disease Therapeutics Day Thursday, October 29, 2020 Panel discussion with Dr. Christian …Lire la suite
A fellow of the Quebec CPA Order, Alain Trudeau has had a distinguished career at Ernst & Young from 1982 to 2019 where he held the position of Managing Partner, Assurance Services, for EY offices in the Province of Quebec from 2008 to 2019. He was also responsible for the audit of many publicly-traded companies. …Lire la suite
Andrew Molson serves as chairman of AVENIR GLOBAL, an organization uniting seven strategic communications firms across Canada, the U.S., Europe and the Middle East. He is also chairman of Molson Coors Beverage Company and a member of the board of directors of Groupe Deschênes Inc., Dundee Corporation and the CH Group Limited Partnership, owner of …Lire la suite